PLx Pharma Inc.
PLXP · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $8,208 | $30 | $565 | $753 |
| % Growth | 26,873.4% | -94.6% | -24.9% | – |
| Cost of Goods Sold | $4,805 | $0 | $0 | $0 |
| Gross Profit | $3,403 | $30 | $565 | $753 |
| % Margin | 41.5% | 100% | 100% | 100% |
| R&D Expenses | $4,182 | $4,339 | $4,741 | $3,923 |
| G&A Expenses | $0 | $9,151 | $10,027 | $7,792 |
| SG&A Expenses | $40,011 | $9,151 | $10,027 | $7,792 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $44,193 | $13,490 | $14,768 | $11,714 |
| Operating Income | -$40,790 | -$13,459 | -$14,202 | -$10,961 |
| % Margin | -497% | -44,229.7% | -2,511.6% | -1,455.5% |
| Other Income/Exp. Net | -$5,335 | -$1,752 | -$6,300 | $11,858 |
| Pre-Tax Income | -$46,125 | -$15,211 | -$20,502 | $896 |
| Tax Expense | $5,335 | -$108 | $837 | $0 |
| Net Income | -$51,460 | -$15,103 | -$21,339 | $896 |
| % Margin | -626.9% | -49,631.9% | -3,773.7% | 119% |
| EPS | -2.18 | -1.55 | -2.39 | 0.1 |
| % Growth | -40.6% | 35.1% | -2,490% | – |
| EPS Diluted | -2.18 | -1.55 | -2.39 | 0.1 |
| Weighted Avg Shares Out | 23,650 | 9,715 | 8,916 | 8,733 |
| Weighted Avg Shares Out Dil | 23,650 | 9,715 | 8,916 | 8,733 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $405 | $298 |
| Interest Expense | $1 | $308 | $995 | $1,146 |
| Depreciation & Amortization | $5,549 | $416 | $405 | $201 |
| EBITDA | -$35,241 | -$14,487 | -$13,797 | $2,243 |
| % Margin | -429.3% | -47,607.9% | -2,440% | 297.9% |